Antifungal agents for preventing fungal infections in solid organ transplant recipients.
@article{Playford2004AntifungalAF, title={Antifungal agents for preventing fungal infections in solid organ transplant recipients.}, author={E. Playford and A. Webster and T. Sorell and J. Craig}, journal={The Cochrane database of systematic reviews}, year={2004}, volume={3}, pages={ CD004291 } }
BACKGROUND
Invasive fungal infections (IFIs) are important causes of morbidity and mortality in solid organ transplant recipients.
OBJECTIVES
This study aims to systematically identify and summarise the effects of antifungal prophylaxis in solid organ transplant recipients.
SEARCH STRATEGY
The Cochrane Central Register of Controlled Trials (Issue 3, 2003), MEDLINE (1966-June 2003), and EMBASE (1980-June 2003) were searched. Reference lists, abstracts of conference proceedings and scientific… Expand
Figures, Tables, and Topics from this paper
86 Citations
Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.
- Medicine
- The Cochrane database of systematic reviews
- 2006
- 73
- PDF
Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials.
- Medicine
- The Journal of antimicrobial chemotherapy
- 2006
- 143
- PDF
Antifungal Prophylaxis in Liver Transplantation: A Systematic Review and Network Meta‐Analysis
- Medicine
- American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
- 2014
- 20
Epidemiology and Management of Candidiasis in Solid Organ Transplant Recipients
- Medicine
- Current Fungal Infection Reports
- 2016
- 1
Outcomes of antifungal prophylaxis in high‐risk liver transplant recipients
- Medicine
- Transplant infectious disease : an official journal of the Transplantation Society
- 2009
- 42
- PDF
Italian guidelines for diagnosis, prevention, and treatment of invasive fungal infections in solid organ transplant recipients.
- Medicine
- Transplantation proceedings
- 2011
- 22
Antifungal prophylaxis in liver transplant patients: A systematic review and meta‐analysis
- Medicine
- Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
- 2006
- 132
- Highly Influenced
Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.
- Medicine
- The Cochrane database of systematic reviews
- 2016
- 38
Methods of preventing bacterial sepsis and wound complications after liver transplantation.
- Medicine
- The Cochrane database of systematic reviews
- 2014
- 36
References
SHOWING 1-10 OF 50 REFERENCES
Antifungal prophylaxis in liver transplant recipients: a randomized placebo‐controlled study
- Medicine
- Transplant international : official journal of the European Society for Organ Transplantation
- 2002
- 38
- PDF
Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: a prospective, randomized, double-blind study
- Medicine
- Transplantation
- 2003
- 55
Invasive mycoses in organ transplant recipients: controversies in prophylaxis and management.
- Medicine
- The Journal of antimicrobial chemotherapy
- 2000
- 16
- Highly Influential
- PDF
Fungal infections in solid-organ transplantation.
- Medicine
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
- 1993
- 350
- PDF
[Prevention of mycotic infections in liver transplant recipients: comparison of two chemoprophylactic protocols].
- Medicine
- Minerva anestesiologica
- 2001
- 3
Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. A randomized, placebo-controlled study.
- Medicine
- Transplantation
- 1995
- 170
Clinical spectrum of fungal infections after orthotopic liver transplantation.
- Medicine
- Archives of surgery
- 1991
- 177
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.
- Medicine
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
- 2002
- 2,279
- PDF